APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
48 hedge funds and large institutions have $18.8M invested in Aptose Biosciences, Inc. in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $39M → $18.8M (-$20.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
48
Holding in Top 10
–
Calls
$158K
Puts
$6K
Top Buyers
| 1 | +$255K | |
| 2 | +$142K | |
| 3 | +$111K | |
| 4 |
Morgan Stanley
New York
|
+$59.8K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$37.7K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$466K | |
| 3 | -$400K | |
| 4 |
PM
Precept Management
Dallas,
Texas
|
-$309K |
| 5 |
Two Sigma Investments
New York
|
-$268K |